Reduced anticoagulation strategy is associated with a lower incidence of intracerebral hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation.

Daniel A HofmaennerDavid FurfaroLennart C WildPedro David Wendel-GarciaElias Baedorf KassisAmeeka PannuTobias WelteRolf ErlebachKlaus StahlEdward Wilson GrandinChristian PutensenReto A SchuepbachShahzad ShaefiSascha DavidBenjamin SeeligerChristian Bodenull null

Published in: Intensive care medicine experimental (2023)

For COVID-19 patients on VV ECMO support anticoagulated with heparin, a lower anticoagulation target was associated with a significant reduction in ICH incidence and increased survival.

Keyphrases

extracorporeal membrane oxygenation
acute respiratory distress syndrome
venous thromboembolism
sars cov
atrial fibrillation
risk factors
respiratory failure
brain injury
growth factor
free survival